Bio-Technology General Corp. has raised $3.1 million in aprivate placement of 590,471 units of common stock andwarrants, the New York company announced Monday.

Each unit, priced at $5.25, includes one share of common stockand a warrant to purchase one-half share of common stock at$8 per whole share. The warrants will expire on either Aug. 26,1995, or when the stock price reaches $13, whichever comesfirst. BTGC stock (NASDAQ:BTGC) closed at $5.63, down 25cents, on Monday. After the placement, BTCG has 21.9 millionshares outstanding.

The investment was led by Evergreen Canada IsraelInvestments and Co. Ltd. and Israel Brokerage and InvestmentsI.B.I. Ltd. Other participants included Israeli insurancecompanies and the Apotex group of Canada. If other investorsjoin the group, the total placement may be increased to $6million by Aug. 30.

(c) 1997 American Health Consultants. All rights reserved.